Biosensor-based multiple cross displacement amplification platform for visual and rapid identification of hepatitis C virus
© 2024 Wiley Periodicals LLC..
Hepatitis C remains a global health problem, especially in poverty-stricken areas. A rapid and sensitive point-of-care (POC) diagnostic tool is critical for the early detection and timely treatment of hepatitis C virus (HCV) infection. Here, for the first time, we reported a novel molecular diagnostic assay, termed reverse transcription multiple cross displacement amplification integrated with a gold-nanoparticle-based lateral flow biosensor (RT-MCDA-AuNPs-LFB), which was developed for rapid, sensitive, specific, and visual identification of HCV. HCV-RT-MCDA induced rapid isothermal amplification through a specific primer set targeting the 5'untranslated region gene from the major HCV genotypes 1b, 2a, 3b, 6a, and 3a that are prevalent in China. The optimal reaction temperature and time for RT-MCDA-AuNPs-LFB were 68°C and 25 min, respectively. The limit of detection of the assay was 10 copies per test, and the specificity was 100% for the experimental strains. The whole detection procedure, including crude nucleic acid isolation (~5 min), RT-MCDA (68°C, 25 min), and visual AuNPs-LFB result confirmation (less than 2 min), was performed within 35 min. The preliminary results indicated that the HCV-RT-MCDA-AuNPs-LFB assay could be a valuable tool for sensitive, specific, visual, cost-saving, and rapid detection of HCV and has potential as a POC diagnostic platform for field screening and early clinical detection of HCV infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
---|---|
Enthalten in: |
Journal of medical virology - 96(2024), 3 vom: 01. März, Seite e29481 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Xu [VerfasserIn] |
---|
Links: |
---|
Themen: |
7440-57-5 |
---|
Anmerkungen: |
Date Completed 04.03.2024 Date Revised 04.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/jmv.29481 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369150821 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369150821 | ||
003 | DE-627 | ||
005 | 20240304232756.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240301s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jmv.29481 |2 doi | |
028 | 5 | 2 | |a pubmed24n1316.xml |
035 | |a (DE-627)NLM369150821 | ||
035 | |a (NLM)38425184 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Xu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Biosensor-based multiple cross displacement amplification platform for visual and rapid identification of hepatitis C virus |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.03.2024 | ||
500 | |a Date Revised 04.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024 Wiley Periodicals LLC. | ||
520 | |a Hepatitis C remains a global health problem, especially in poverty-stricken areas. A rapid and sensitive point-of-care (POC) diagnostic tool is critical for the early detection and timely treatment of hepatitis C virus (HCV) infection. Here, for the first time, we reported a novel molecular diagnostic assay, termed reverse transcription multiple cross displacement amplification integrated with a gold-nanoparticle-based lateral flow biosensor (RT-MCDA-AuNPs-LFB), which was developed for rapid, sensitive, specific, and visual identification of HCV. HCV-RT-MCDA induced rapid isothermal amplification through a specific primer set targeting the 5'untranslated region gene from the major HCV genotypes 1b, 2a, 3b, 6a, and 3a that are prevalent in China. The optimal reaction temperature and time for RT-MCDA-AuNPs-LFB were 68°C and 25 min, respectively. The limit of detection of the assay was 10 copies per test, and the specificity was 100% for the experimental strains. The whole detection procedure, including crude nucleic acid isolation (~5 min), RT-MCDA (68°C, 25 min), and visual AuNPs-LFB result confirmation (less than 2 min), was performed within 35 min. The preliminary results indicated that the HCV-RT-MCDA-AuNPs-LFB assay could be a valuable tool for sensitive, specific, visual, cost-saving, and rapid detection of HCV and has potential as a POC diagnostic platform for field screening and early clinical detection of HCV infection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HCV | |
650 | 4 | |a RT-MCDA | |
650 | 4 | |a biosensor | |
650 | 4 | |a hepatitis C | |
650 | 4 | |a point-of-care testing | |
650 | 7 | |a Gold |2 NLM | |
650 | 7 | |a 7440-57-5 |2 NLM | |
700 | 1 | |a Dong, Shilei |e verfasserin |4 aut | |
700 | 1 | |a Shi, Yuanfang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Zengguang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xue |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Xiaoyan |e verfasserin |4 aut | |
700 | 1 | |a Yang, Xinggui |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Qi |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Zhenghua |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Qingxue |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 96(2024), 3 vom: 01. März, Seite e29481 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
773 | 1 | 8 | |g volume:96 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:e29481 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.29481 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 96 |j 2024 |e 3 |b 01 |c 03 |h e29481 |